One-stop Mitochondria-focused Testing Services Targeting to Preclinical Studies of Cardiac Diseases

Creative Biogene offers one-stop mitochondria-focused testing services for the evaluation of a variety of cardiac diseases associated with mitochondrial dysfunction.

MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth

MMS Holdings, a contract research organization, announced today that Lindsay Goldberg, a private equity firm, has completed an investment in the company. The partnership will help MMS expand its data-focused clinical research services.

Creative Proteomics Cytokine Boosts Your Research and Discovery with Mouse Cytokine Assay

Creative Proteomics Lipidomics Introduces Glycerophospholipids Analysis Service

Creative Proteomics Metabolomics Expands Service Offering with the Launch of Food Metabolomics Service

‘My Healthy Maryland’ Study Launches on Vibrent Health Platform, Using Next-Generation Digital Research Tools to Create Biggest and Most Diverse Health Database in State

University of Maryland Medicine Precision Health Study Utilizes Vibrent Health’s Accessible and Scalable Online Platform with a Goal to Enroll 250,000 Diverse Maryland Residents to Learn How Genes and Other Factors Affect Health

Cotiviti to Share Expertise on the Role of Quality in Improving Healthcare Outcomes at RISE Qualipalooza Conference

Senior Vice President Rachael Jones to co-chair RISE event focused on improving quality of care and member experience

ObvioHealth announces a groundbreaking partnership with Dedalus Group to unite real world & clinical trial data

ObvioHealth, a global virtual research organization (VRO), is bringing clinical trial data fully into the continuum of care through a new strategic partnership with Dedalus Group, the leading healthcare and diagnostic software solutions provider in Europe.

Novel PTSD Treatment Advances Toward Regulatory Evaluation with New Collaboration Between MAPS PBC and MMS Holdings

On PTSD Awareness Day, MAPS PBC announces plans to develop the New Drug Application for MDMA-assisted therapy in collaboration with MMS Holdings The second Phase 3 trial of the Breakthrough-Designated Therapy for PTSD will be completed in late 2022, with a targeted NDA submission in 2023 supported by MMS Holdings MMS Holdings, which specializes in supporting first-in-class NDAs, was selected for extensive experience in neuroscience

MicrobioSeq Boosts Microbial Diversity Research with Eukaryotic 18S rRNA Sequencing

Amerigo Scientific Announces the Launch of Extra Large Drying Traps

Amerigo Scientific introduces new extra large Drying Traps for research application.

Global Active Pharmaceutical Ingredients Market Is Expected To Grow With The CAGR Of More Than 6.8% By 2027

Global Active Pharmaceeutical Ingredients Market size, share, trends, growth, opportunity, forecast

5th Edition of World Nanotechnology Conference

CD BioSciences Announces Solubilization and Stabilization Solution to Simplify GPCR Research

CD BioSciences introduces GPCR solubilization and stabilization services to researchers to advance scientific programs in GPCR research and drug development.

STEMart Launches Microbiology & Sterility Testing Services for Medical Devices

STEMart introduces comprehensive microbiology and sterility testing for sterile, non-pyrogenic products.

Creative Diagnostics Introduces CC50/IC50 Assay Services for Pharmaceutical Safety

Creative Diagnostics introduced CC50/IC50 testing services with a high level of detection sensitivity and accuracy.

Jumo Health Helps Young People to Become Effective Patient Advocates

Jumo Health, a global provider of age appropriate, culturally sensitive, medical education resources, today announced that it is extending its ongoing support of the International Children’s Advisory Network (iCAN), a global consortium of youth advisory groups. iCAN empowers pediatric patients worldwide and provides a voice for children and their families in healthcare, clinical trials, and medical research.

Fuel Cell Catalysts for Renewable Energy Industry

CD Formulation Enables Customized Synthesis Service for Osmotic Pressure Regulators

Normal cell function requires the maintenance of osmotic pressure. Therefore, in drug manufacturing, osmotic pressure regulators should be added to the formulation to avoid tissue damage. The US-based CRO company CD Formulation recently announced its ability to synthesize osmotic pressure regulators to suit the needs of different drug projects. These osmotic pressure regulators will help parenteral preparations to keep isotonic with human plasma.

Creative Enzymes Introduces DNA Modifying Enzymes for Molecular Biology Research